Publications by authors named "Julia Opolski Nunes da Silva"
Once-Weekly Insulin Icodec . Once-Daily Insulin Glargine U100 for type 2 diabetes: a systematic review and meta-analysis of phase 2 randomized controlled trials.
Rodrigo Ribeiro E Silva Mateus de Miranda Gauza Maria Eduarda Schramm Guisso Júlia Opolski Nunes da Silva Suely Keiko Kohara
Arch Endocrinol Metab
May 2023
Objective: Insulin Icodec is a novel basal insulin analogue designed for once-weekly administration, therefore might propitiate reduction in the frequency of injections and facilitate treatment adherence. This study aimed to determine the glycemic control and safety profile of Insulin Icodec, compared with Glargine U100 in patients with diabetes mellitus type 2.
Materials And Methods: We performed a systematic review and meta-analysis of randomized controlled trials (RCT) data comparing OnceWeekly Insulin Icodec and Once-Daily Insulin Glargine U100 in patients with type 2 diabetes mellitus.